INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Clinical trial NCT06282692 · UNKNOWN
Trial details
- NCT number
- NCT06282692
- Sponsor
- Dr. Soetomo General Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-05-19
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.